EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A modified α-synuclein seed amplification assay in Lewy body dementia using Raman spectroscopy and machine learning analysis

Nathan P Coles, Suzan Elsheikh, Alaa Gouda, Agathe Quesnel, Lucy Butler, Ojodomo J Achadu, Meez Islam, Karunakaran Kalesh, Annalisa Occhipinti, Claudio Angione, Jon Marles-Wright, David J Koss und 4 weitere

Journal of Neuroscience Methods · 2026-01 · 425 · 110617

DOI: 10.1016/j.jneumeth.2025.110617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroscience Methods, 2026-01. Verfasst von Nathan P Coles und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Health & Life Sciences, Teesside University, Middlesbrough TS1 3BX, United Kingdom; National Horizons Centre, Teesside University, Darlingt…. Hauptthemen laut MEDLINE: Lewy Body Disease, alpha-Synuclein, Spectrum Analysis, Raman, Machine Learning. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Research UK, Newcastle University, Teesside University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lewy body dementias (LBD), comprising dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), are defined by misfolded α-synuclein aggregation. Seed amplification assays (SAAs), such as RT-QuIC, enable sensitive detection of α-synuclein aggregates but typically provide binary readouts and require fluorescence labeling. Raman spectroscopy offers a label-free approach to detect subtle biochemical changes, and its diagnostic potential can be enhanced with machine learning. OBJECTIVES: This proof-of-concept study aimed to evaluate whether Raman spectroscopy combined with machine learning can improve SAA-based discrimination of LBD from controls in cerebrospinal fluid (CSF). METHODS: We analyzed a small number of post-mortem CSF samples from pathologically confirmed DLB (n = 2), PDD (n = 2), and controls (n = 2) using a 7-day SAA. Raman spectra were collected on Days 1, 4, and 7 and analyzed using principal component analysis (PCA) and uniform manifold approximation and projection (UMAP). RESULTS: Following SAA, both PCA and UMAP distinguished combined LBD samples from controls within 24 h (Day 1), reflecting biochemical changes consistent with α-synuclein fibrillation. Spectral shifts indicated decreased α-helical content with increased β-sheet structures. No consistent separation between DLB and PDD was observed. CONCLUSION: This preliminary study demonstrates that combining Raman spectroscopy with machine learning can enable rapid, label-free detection of disease-specific changes. Despite the very limited sample size, these findings highlight the potential of this novel workflow and strongly warrant its validation in larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lewy Body Diseasealpha-SynucleinSpectrum Analysis, RamanMachine LearningHumansMaleFemaleAgedAged, 80 and overProof of Concept StudyParkinson DiseasePrincipal Component AnalysisBiomarkers

Stichwörter der Autor:innen

DiagnosticsLewy body dementiaMachine learning analysisRaman spectroscopyα-synuclein aggregation

Substanzen

alpha-SynucleinBiomarkers

Autor:innen und Institutionen

  • School of Health & Life Sciences, Teesside University, Middlesbrough TS1 3BX, United Kingdom; National Horizons Centre, Teesside University, Darlington DL1 1HG, United Kingdom.
  • Research Center In Cancer De Toulouse, 2 Av. Hubert Curien, Toulouse 31100, France.
  • National Horizons Centre, Teesside University, Darlington DL1 1HG, United Kingdom; School of Computing, Engineering & Digital Technologies, Teesside University, Middlesbrough TS1 3BX, United Kingdom; Centre for Digital…
  • Biosciences Institute, Cookson Building, Framlington Place, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Division of Neuroscience, School of Medicine, University of Dundee, Nethergate, Dundee, Scotland DD1 4HN, United Kingdom.
  • Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.

Förderung

  • Alzheimer's Research UK
  • Newcastle University
  • Teesside University

Zitieren

APA

Coles, N. P., Elsheikh, S., Gouda, A., Quesnel, A., Butler, L., Achadu, O. J., Islam, M., Kalesh, K., Occhipinti, A., Angione, C., Marles-Wright, J., Koss, D. J., Thomas, A. J., Outeiro, T. F., Filippou, P. S., & Khundakar, A. A. (2026). A modified α-synuclein seed amplification assay in Lewy body dementia using Raman spectroscopy and machine learning analysis. Journal of Neuroscience Methods, 425, 110617. https://doi.org/10.1016/j.jneumeth.2025.110617

Vancouver

Coles NP, Elsheikh S, Gouda A, Quesnel A, Butler L, Achadu OJ, et al. A modified α-synuclein seed amplification assay in Lewy body dementia using Raman spectroscopy and machine learning analysis. Journal of Neuroscience Methods. 2026;425:110617. doi:10.1016/j.jneumeth.2025.110617

BibTeX
@article{Coles2026,
  author = {Coles, Nathan P and Elsheikh, Suzan and Gouda, Alaa and Quesnel, Agathe and Butler, Lucy and Achadu, Ojodomo J and Islam, Meez and Kalesh, Karunakaran and Occhipinti, Annalisa and Angione, Claudio and Marles-Wright, Jon and Koss, David J and Thomas, Alan J and Outeiro, Tiago F and Filippou, Panagiota S and Khundakar, Ahmad A},
  title = {A modified α-synuclein seed amplification assay in Lewy body dementia using Raman spectroscopy and machine learning analysis},
  journal = {Journal of Neuroscience Methods},
  year = {2026},
  volume = {425},
  pages = {110617},
  doi = {10.1016/j.jneumeth.2025.110617}
}
Kostenlos starten →